期刊文献+

653份乳腺癌组织标本的ER-α36表达结果分析 被引量:1

Analysis of ER-α36 expression in 653 cases of breast cancer tissues
下载PDF
导出
摘要 目的研究雌激素受体α36亚型(ER-α36)在乳腺癌组织的表达状态及其与乳腺癌发生、发展及临床预后的关系。方法选取653份乳腺癌组织标本,用实时荧光定量聚合酶链反应(RT-PCR)技术和免疫组化技术检测组织中ER-α36、雌激素受体α66亚型(ER-α66)、孕激素受体(PR)和人表皮生长因子受体-2(Her-2)的表达,分析ER-α36的表达与上述指标及临床病理特征之间的关系。结果 ER-α36的总体表达率为40%;在Her-2阳性组织中的表达率为63%,明显高于阴性组的44%(P<0.05);在ER-α66/PR/Her-2三阴性组织中的表达率为66%,明显高于非三阴性组的35%(P<0.05);在ER-α66阳性和阴性标本中及在PR阳性和阴性标本中的表达率差异无统计学意义(P>0.05);在Ⅲ+Ⅳ期乳腺癌组织中的阳性表达率(54%)明显高于Ⅰ+Ⅱ期的28%(P<0.05);在淋巴结转移阳性乳腺癌组织中的表达率(55%)明显高于无转移组织的23%(P<0.05)。结论 ER-α36可能在乳腺癌的发生、发展及淋巴结转移过程中具有重要作用,并与Her-2的表达、乳腺癌分期及淋巴结转移有关,有望成为新的肿瘤标记物及临床诊治的新靶点。 Objective To study the expression status of estrogen receptor-alpha36(ER-α36)in breast cancer tissue and its rela-tionships with the occurrence,development and clinical prognosis of breast cancer.Methods 653 cases of breast cancer tissues were selected in this study.The real-time reverse transcription polymerase chain reaction(RT-PCR)and immunohistochemistry were used to detect the expression of ER-α36,estrogen receptor-alpha66 (ER-α66),progesterone receptor(PR)and human epidermal growth factor receptor-2(Her-2).The relationships between the expression of ER-α36,ER-α66,PR and Her-2 and the pathological charac-ter were analyzed.Results The expression rate of ER-α36 in all cases was 40%.The expression rate of ER-α36 in Her-2 positive tissues(63%)was significantly higher than that in the Her-2 negative group(44%,P 〈0.05).The expression rate of ER-α36 in ER-α66/PR/Her-2 negative tissues(66%)was significantly higher than that in the non-three-negative group(35%,P 〈0.05).The differences of ER-α36 expression rate between ER-α66 positive samples and negative samples or between PR positive and negative samples showed no statistical significance(P 〉 0.05).The expression rate of ER-α36 in stage Ⅲ+Ⅳ breast cancer tissues(54%) was significantly higher than that in stage Ⅰ+Ⅱ breast cancer tissues(28%,P 〈0.05).The expression rate of ER-α36 in breast cancer tissues with lymph node metastasis (55%)was significantly higher than that in breast cancer tissues without lymph node me-tastasis (23%,P 〈0.05).Conclusion The results indicate that ER-α36 may play a very important role in the occurrence,develop-ment and lymph node metastasis of breast cancer,and be associated with the expression of Her-2,breast cancer staging and lymph node metastasis.ER-α36 is expected to become a new tumor marker and clinical diagnosis and treatment target.
出处 《国际检验医学杂志》 CAS 2015年第13期1851-1853,共3页 International Journal of Laboratory Medicine
关键词 乳腺癌 雌激素受体α36亚型 雌激素受体α66亚型 孕激素受体 人表皮生长因子受体-2 breast cancer estrogen receptor-alpha36 estrogen receptor-alpha66 progesterone receptor human epider-mal growth factor receptor-2
  • 相关文献

参考文献2

二级参考文献46

  • 1McEwen B. Estrogen actions throughout the brain. RecentProg Horm Res 2002; 57: 357-384. 被引量:1
  • 2Nilsson S,Makela S, Treuter E, Tujague M, Thomsen J, An-dersson G, Enmark E, Pettersson K, Warner M, GustafssonJA. Mechanisms of estrogen action. Physiol Rev 2001;81(4): 1535-1565. 被引量:1
  • 3Frye CA, Duffy CK, Waif AA. Estrogens and progestins en-hance spatial learning of intact and ovariectomized rats inthe object placement task. Neurobiol Learn Mem 2007;88(2):208-216. 被引量:1
  • 4Guo J, Duckies SP, Weiss JH, Li X, Krause DN. 17beta-Estradiol prevents cell death and mitochondrial dysfunctionby an estrogen receptor-dependent mechanism in astrocytesafter oxygen-glucose deprivation/reperfusion. Free RadicBiol Med 2012; 52(11-12): 2151-2160. 被引量:1
  • 5Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafs-son JA. Cloning of a novel receptor expressed in rat prostateand ovary. Proc Natl Acad Sci USA 1996; 93(12): 5925-5930. 被引量:1
  • 6Kelly MJ, Levin ER. Rapid actions of plasma membrane es-trogen receptors. Trends Endocrinol Metab 2001; 12(4):152-156. 被引量:1
  • 7Segars JH, Driggers PH. Estrogen action and cytoplasmicsignaling cascades. Part I: membrane-associated signalingcomplexes. Trends Endocrinol Metab 2002; 13(8): 349-354. 被引量:1
  • 8Wang ZY, Zhang XT, Shen P,Loggie BW, Chang Y,DeuelTF. Identification, cloning, and expression of human estro-gen receptor-alpha36, a novel variant of human estrogen re-ceptor-alpha66. Biochem Biophys Res Commun 2005;336(4): 1023-1027. 被引量:1
  • 9Lee LM,Cao J, Deng H,Chen P, Gatalica Z, Wang ZY. ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. AnticancerRes 2008; 28(1B): 479^83. 被引量:1
  • 10Tu BB, Lin SL, Yan LY, Wang ZY, Sun QY,Qiao J. ER-alpha36, a novel variant of estrogen receptor alpha, isinvolved in EGFR-related carcinogenesis in endometrialcancer. Am J Obstet Gynecol 2011; 205(3): 227.el-227.e6. 被引量:1

共引文献14

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部